Regenerative Medicine

Geneva facilitates next-generation technologies and promising research to speed the delivery of regenerative medicine therapies for injured warfighters and accelerate return-to-duty.

Geneva collaborates with a multitude of academic and industry stakeholders in regenerative medicine at federal laboratories and military treatment facilities including: National Cancer Institute, Uniformed Services University, Walter Reed National Military Medical Center, and Walter Reed Army Institute of Research.

Performance Capabilities

Geneva researchers have vast experience in developing biologics and cell therapies in regenerative medicine, with expertise in areas including:

  • Access to BSL-2 and BSL-3 facilities
  • Bioengineering
  • Creation of educational initiatives, including biotechnology courses
  • Development of biotechnologies and therapeutics
  • Development of training opportunities
  • Expansion of maturing technologies for advanced development
  • Expediting product development through preclinical and clinical
  • Onsite and rapid biofabrication
  • Stem cell therapy applications such as wound healing
  • Utilization of medical simulation

Featured Program

The USU-4D Bio3: 4-Defense Biotechnology, Biomanufacturing, and Bioprinting Center promotes the development and application of advanced bioprinting, biofabrication, and biomanufacturing technologies for research pursuant to Department of Defense priorities and for translation to clinical medical defense care and training solutions.

Learn more

Geneva Expertise

Researcher of the Year
LTC (Ret.) Luis Alvarez, PhD

LTC Alvarez is leading innovative research in developing biologics and cell therapies in regenerative medicine.

 
Researcher of the Year
Vincent Ho, MD, MBA

Dr. Ho is spearheading the development of novel techniques and technological advancements in imaging.

 
Featured Employee
Frank Alexander, PhD

Geneva research scientist Dr. Alexander is helping to develop bioprinting technique for corneas using electrospinning.

 

Watch Video

Learn more about the USU-4DBio3 Center, its capabilities, and ways to get involved.

Research Indications

Geneva has diverse experience in managing regenerative medicine programs in areas including:

3D Bioprinting
Biofabrication
Biomaterial Formulation and Injection
Biobanking
Gene Therapy
Medical Devices
OrthoBiologics
Personalized Multi Omics Screening
Stem Cell and Minimally Modified Cell-based Therapies
Tissue Engineering